Procter & Gamble price target raised to $175 from $170 at BofA

BofA raised the firm’s price target on Procter & Gamble to $175 from $170 and keeps a Buy rating on the shares. Following the company’s fiscal Q4 report, BofA forecasts Q1 organic sales growth of 5% funding 8% EPS growth and expects relatively organic sales will remain stable across quarters, culminating in 5% growth for the full year, “increasingly driven by volume instead of price,” the analyst tells investors.